Hussman Strategic Advisors, Inc. Vericel Corp Call Options Transaction History
Hussman Strategic Advisors, Inc.
- $407 Million
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding VCEL
# of Institutions
290Shares Held
54.1MCall Options Held
36.7KPut Options Held
6.4K-
Black Rock Inc. New York, NY8.06MShares$292 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.49MShares$127 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD2.88MShares$105 Million3.98% of portfolio
-
Conestoga Capital Advisors, LLC2.46MShares$89.4 Million1.56% of portfolio
-
State Street Corp Boston, MA2.44MShares$88.4 Million0.0% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $1.71B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...